
Great read @thebandlab! It is a remarkable time for the future of psychedelic medicines and we are proud to be part of the developments alongside a remarkable team.

The Translational Psychedelics Research Program brings together scientists and providers to understand how psychedelics impact the brain and other organ systems

Great read @thebandlab! It is a remarkable time for the future of psychedelic medicines and we are proud to be part of the developments alongside a remarkable team.

We @TrPR_Program @ucsf agree that this is an exciting time for psychedelic research in the Bay! Here’s a link to the ucsf magazine article that describes our efforts @ucsf
Trip therapy: Could psychedelics become mainstream medicines? Read for more about the future of psychedelic medicines: ucsfpsy.ch/3R5ALLQ @thebandlab @RCarhartHarris

As we are talking about psychedelic research at @ucsf and @StanfordMed, would like to highlight our ongoing collaboration w/ @TheBorisLab on a trial of psilocybin for chronic low back pain starting recruitment shortly.

I had a great time interviewing Dr. David Gard about psilocybin-assisted therapy, and how psychologists may be integrating such tools into future practice. He also shared some updates about the @TrPR_Program trial of 🍄 for depression in #bipolardisorder type 2. More 📽️ to come!
NEW EPISODE! #talkBD🍄 Researcher/psychologist Dr. David Gard breaks down the latest research on psychedelics in supporting mental health, use of psilocybin to treat #bipolar, and reviews the benefits and risks. 📺Stream on YouTube/all podcast platforms: talkBD.live/psilocybin

Survey study on meds in individuals with an eating disorder, please share. redcap.sydney.edu.au/surveys…

Nice to see @TrPR_Program work referenced in the NYT nytimes.com/2023/02/10/well/… risk of psychedelics causing mania/psychosis especially in people with personal or fam hx of bipolar is complex. If it occurs, the rates must be very low. We are conducting a trial in bd2 to learn more.

Are you or someone you know currently depressed and have bipolar 2 disorder? @Trpr_program is recruiting for a trial of psilocybin therapy. To learn more, for to psychedelics.ucsf.edu or email psilocybinstudies@ucsf.edu.

An international web-based survey on experiences of psilocybin consumption found that 32.2% of respondents w/ bipolar disorder described new/increasing symptoms after psilocybin trips. ucsfpsy.ch/40tG5gu

Excited to announce a new milestone for TrPR. This week we successfully dosed three participants with psilocybin. Our capacity to deliver psychedelic therapy is increasing.

A privilege to move this work forward with @TrPR_Program!
The longer people with #anorexia go untreated, “the worse the chance of recovery is," UCSF's Dr. Amanda Downey (@drdowneydoes) says. Downey & team will be studying the impact of psychedelics on younger patients with the #EatingDisorder. ucsfh.org/3VT4l8h

TrPR's @UCSF_AndrewPenn, a psychiatric nurse practitioner and #psychedelic psychotherapy researcher, discusses the key elements of psychedelic-assisted therapy on the latest episode of @psychmedpod. psychedelicmedicineassociati…

@TrPR_Program @EllenBradleyMD @UCSF @UCSFPsychiatry @TheBorisLab @RCarhartHarris @CREST_BD

@TrPR_Program @EllenBradleyMD @UCSF @UCSFPsychiatry @TheBorisLab @RCarhartHarris @CREST_BD

To learn more about this position and the required and preferred qualifications, visit sjobs.brassring.com/TGnewUI/…

The clinical social worker will provide evidence-based psychotherapy under the research protocol. Under the supervision of senior clinical staff, they will provide psychotherapy, using evidence-based practices. They will also provide crisis intervention and emotional support.

TrPR is currently recruiting Cantonese/Mandarin speaking research assistants and facilitators! The primary function of this position is to provide psychotherapy services for the Translational Psychedelic Research Program.